Antibody affinity and cross-variant neutralization of sars-cov-2 omicron ba.1, ba.2 and ba.3 following third mrna vaccination

HIGHLIGHTS

• who: Lorenza Bellusci from the consent, and data collection documents were reviewed and approved by the WIRB-Copernicus Group Institutional Review Board (WCG IRB #202029060) and the University of GeorgiaAll patients provided written informed consent. Consent on this study included agreement for the use of remnant material for additional immunological assays at the time of study enrollment. Samples were tested in different antibody assays with approval from the U.S. Food and Drug Administration`s Research Involving Human Subjects Committee (FDA-RIHSC) under exemption protocol u2018252-Determination- CBER-2020-08-19. All samples were tested in duplicates . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.